480 related articles for article (PubMed ID: 19625223)
21. [Cholestatic hepatitis associated with nimesulide--a case report].
Lukić S; Krstić M; Damjanov N; Boricić I; Popović D; Djuranović S; Kovacević N; Tomanović N
Srp Arh Celok Lek; 2009; 137(9-10):550-3. PubMed ID: 19950766
[TBL] [Abstract][Full Text] [Related]
22. Fatal hepatoxicity secondary to nimesulide.
Merlani G; Fox M; Oehen HP; Cathomas G; Renner EL; Fattinger K; Schneemann M; Kullak-Ublick GA
Eur J Clin Pharmacol; 2001 Jul; 57(4):321-6. PubMed ID: 11549211
[TBL] [Abstract][Full Text] [Related]
23. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.
Lucena MI; Kaplowitz N; Hallal H; Castiella A; García-Bengoechea M; Otazua P; Berenguer M; Fernandez MC; Planas R; Andrade RJ
J Hepatol; 2011 Oct; 55(4):820-7. PubMed ID: 21338638
[TBL] [Abstract][Full Text] [Related]
24. [Clinical characteristics of drug-induced liver injury in 31 pediatric cases].
Wang SZ; Gao S; Liu YM; Huang YL; Chen YS; Wang XX; Lin W; Huang CY; Liao HY
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):193-5. PubMed ID: 22475138
[TBL] [Abstract][Full Text] [Related]
25. Nimesulide-induced fulminant hepatitis.
Ozgür O; Hacihasanoğlu A; Karti SS; Ovali E
Turk J Gastroenterol; 2003 Sep; 14(3):208-10. PubMed ID: 14655069
[TBL] [Abstract][Full Text] [Related]
26. Celecoxib-induced Liver Injury: Analysis of Published Case Reports and Cases Reported to the Food and Drug Administration.
Mukthinuthalapati PK; Fontana RJ; Vuppalanchi R; Chalasani N; Ghabril M
J Clin Gastroenterol; 2018 Feb; 52(2):114-122. PubMed ID: 28795997
[TBL] [Abstract][Full Text] [Related]
27. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.
Chalasani N; Fontana RJ; Bonkovsky HL; Watkins PB; Davern T; Serrano J; Yang H; Rochon J;
Gastroenterology; 2008 Dec; 135(6):1924-34, 1934.e1-4. PubMed ID: 18955056
[TBL] [Abstract][Full Text] [Related]
28. Steroid therapy for a case of severe drug-induced cholestasis.
Giannattasio A; D'Ambrosi M; Volpicelli M; Iorio R
Ann Pharmacother; 2006 Jun; 40(6):1196-9. PubMed ID: 16720710
[TBL] [Abstract][Full Text] [Related]
29. Drug-induced liver disease: an 8-year study of patients from one gastroenterological department.
Wang YP; Shi B; Chen YX; Xu J; Jiang CF; Xie WF
J Dig Dis; 2009 Aug; 10(3):195-200. PubMed ID: 19659787
[TBL] [Abstract][Full Text] [Related]
30. Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?
Vuppalanchi R; Liangpunsakul S; Chalasani N
Am J Gastroenterol; 2007 Mar; 102(3):558-62; quiz 693. PubMed ID: 17156142
[TBL] [Abstract][Full Text] [Related]
31. Adverse drug reactions and organ damage: The liver.
Licata A
Eur J Intern Med; 2016 Mar; 28():9-16. PubMed ID: 26827101
[TBL] [Abstract][Full Text] [Related]
32. Fatal hepatitis and renal failure during treatment with nimesulide.
Schattner A; Sokolovskaya N; Cohen J
J Intern Med; 2000 Jan; 247(1):153-5. PubMed ID: 10672143
[TBL] [Abstract][Full Text] [Related]
33. Nimesulide-induced electrophile stress activates Nrf2 in human hepatocytes and mice but is not sufficient to induce hepatotoxicity in Nrf2-deficient mice.
Kale VM; Hsiao CJ; Boelsterli UA
Chem Res Toxicol; 2010 May; 23(5):967-76. PubMed ID: 20405857
[TBL] [Abstract][Full Text] [Related]
34. Features and outcomes from a retrospective study of 570 hospitalized Chinese patients with drug-induced liver injury.
Pang L; Yang W; Hou F
Clin Res Hepatol Gastroenterol; 2018 Feb; 42(1):48-56. PubMed ID: 28927656
[TBL] [Abstract][Full Text] [Related]
35. [Toxic hepatitis caused by nimesulide, presentation of a new case and review of the literature].
Ferreiro C; Vivas S; Jorquera F; Domínguez AB; Espinel J; Muñoz F; Herrera A; Fernández MJ; Olcoz JL; Ortiz de Urbina J
Gastroenterol Hepatol; 2000 Nov; 23(9):428-30. PubMed ID: 11126038
[TBL] [Abstract][Full Text] [Related]
36. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs.
Traversa G; Bianchi C; Da Cas R; Abraha I; Menniti-Ippolito F; Venegoni M
BMJ; 2003 Jul; 327(7405):18-22. PubMed ID: 12842950
[TBL] [Abstract][Full Text] [Related]
37. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.
Devarbhavi H; Joseph T; Sunil Kumar N; Rathi C; Thomas V; Prasad Singh S; Sawant P; Goel A; Eapen CE; Rai P; Arora A; Leelakrishnan V; Gopalakrishnan G; Vardhan Reddy V; Singh R; Goswami B; Venkataraman J; Balaraju G; Patil M; Patel R; Taneja S; Koshy A; Nagaraja Rao P; Kumar Sarin S; Rathi P; Dhiman R; Duseja AK; Vargese J; Kumar Jain A; Wadhawan M; Ranjan P; Karanth D; Ganesh P; Nijhawan S; Krishna Dhali G; Adarsh CK; Jhaveri A; Nagral A; Rao P; Shalimar
J Clin Exp Hepatol; 2021; 11(3):288-298. PubMed ID: 33994711
[TBL] [Abstract][Full Text] [Related]
38. Clinical Characteristics of Patients with Drug-induced Liver Injury.
Yang LX; Liu CY; Zhang LL; Lai LL; Fang M; Zhang C
Chin Med J (Engl); 2017 Jan; 130(2):160-164. PubMed ID: 28091407
[TBL] [Abstract][Full Text] [Related]
39. Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases.
Bessone F; Lucena MI; Roma MG; Stephens C; Medina-Cáliz I; Frider B; Tsariktsian G; Hernández N; Bruguera M; Gualano G; Fassio E; Montero J; Reggiardo MV; Ferretti S; Colombato L; Tanno F; Ferrer J; Zeno L; Tanno H; Andrade RJ
Liver Int; 2016 Feb; 36(2):302-10. PubMed ID: 26104271
[TBL] [Abstract][Full Text] [Related]
40. Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period.
Baekdal M; Ytting H; Skalshøi Kjær M
Scand J Gastroenterol; 2017 Apr; 52(4):450-454. PubMed ID: 27973926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]